Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer
Status:
Active, not recruiting
Trial end date:
2023-01-27
Target enrollment:
Participant gender:
Summary
This clinical trial studies stereotactic body radiation therapy in treating patients with
high-risk prostate cancer that has not spread to nearby lymph nodes or to other parts of the
body. Stereotactic body radiation therapy is a specialized radiation therapy that delivers a
single, high dose of radiation directly to the tumor and may kill more tumor cells and cause
less damage to normal tissue. Studying quality of life in patients undergoing stereotactic
body radiation therapy may help identify the long-term effects of treatment on patients with
prostate cancer.